Cardiac Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
Description
Cardiac Monitoring Devices Market Summary
The global cardiac monitoring devices market is expected to increase from USD 21,360.61 million in 2024 to USD 31,602.55 million by 2032, reflecting strong and sustained growth.
The global cardiac monitoring devices market is growing at a CAGR of 5.11% during the forecast period from 2025 to 2032.
The market of cardiac monitoring devices is being primarily driven by the growing instances of cardiovascular diseases and their associated risk factors, increasing demand for remote patient monitoring, technological advancements in the product designs, and an increase in product development activities among the key market players.
The leading companies operating in the cardiac monitoring devices market include Boston Scientific Corporation, Neurosoft, ACS Diagnostics, Medtronic, BIOTRONIK, Abbott, Microport Scientific Corporation, Koninklijke Philips NV, GENERAL ELECTRIC COMPANY, ZOLL Medical Corporation, AliveCor Inc., Bexen Cardio, iRhythm Technologies Inc., Me-Trax GmbH, Osypka Medical GmbH, GE Healthcare, BIOTRONIK SE & Co. KG, Schiller AG, Nihon Kohden Corporation, BPL Medical Technologies Pvt. Ltd., and others.
North America is expected to dominate the overall cardiac monitoring devices market due to the high prevalence of cardiovascular diseases, a large aging population, and the early adoption of advanced technologies such as AI-powered wearables and remote monitoring systems. Strong healthcare infrastructure, supportive reimbursement policies, and continuous FDA approvals for innovative devices further drive growth. Additionally, the presence of leading market players and increasing focus on preventive healthcare reinforce the region’s dominant position.
In the product type segment of the cardiac monitoring devices market, the ECG devices category is estimated to account for the largest market share in 2024.
Factors Contributing to the Growth of the Cardiac Monitoring Devices Market
Growing instances of cardiovascular diseases and their associated risk factors leading to a surge in cardiac monitoring devices: The growing instances of cardiovascular diseases, along with associated risk factors such as obesity, diabetes, hypertension, and sedentary lifestyles, are driving a surge in demand for cardiac monitoring devices. With heart conditions becoming a leading cause of morbidity and mortality globally, there is an increasing need for early detection, continuous monitoring, and preventive care, which is fueling the widespread adoption of advanced cardiac monitoring technologies.
Increasing demand for remote patient monitoring is escalating the market of cardiac monitoring devices: The increasing demand for remote patient monitoring is significantly escalating the market for cardiac monitoring devices, as it enables continuous, real-time tracking of heart health outside hospital settings. This trend, accelerated by telehealth adoption, supports better management of chronic conditions, reduces hospital readmissions, and improves patient convenience—driving wider use of wearable ECGs, patches, and implantable monitors worldwide.
Technological advancement in product design: Technological advancements in product design are boosting the cardiac monitoring devices market by introducing smaller, smarter, and more patient-friendly solutions such as wearable ECG patches, AI-powered systems, and wireless implantables. These innovations enhance accuracy, comfort, and connectivity, enabling real-time data sharing and personalized care, which in turn drives greater adoption among both patients and healthcare providers.
Cardiac Monitoring Devices Market Report Segmentation
This cardiac monitoring devices market report offers a comprehensive overview of the global Cardiac Monitoring Devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (ECG Devices [Resting ECG, Stress ECG, and Holter Monitors], Implantable Loop Recorders, Event Recorders, Echocardiogram, Mobile Cardiac Telemetry, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing cardiac monitoring devices market.
A cardiac monitoring device is a medical device that helps in the monitoring of heart rhythms. There are numerous types of cardiac monitoring devices, ranging from conventional cardiac monitors to portable and even implantable cardiac monitors. These devices help in the diagnosis of heart rhythm-related disorders as well as alert patients and healthcare providers during adverse events.
The overall market for cardiac monitoring devices is being strongly boosted by the rising prevalence of cardiovascular diseases and related risk factors, which heightens the need for early detection and continuous monitoring. This demand is further amplified by the growing adoption of remote patient monitoring, allowing real-time heart health management beyond clinical settings. At the same time, technological advancements in device design, including AI integration, miniaturization, and wearables, are making solutions more accurate and patient-friendly. Additionally, increased product development activities by key players are expanding device options and accessibility, collectively driving robust market growth.
Get More Insights into the Report @Cardiac Monitoring Devices Market
What are the latest Cardiac Monitoring Devices Market Dynamics and Trends?
The cardiac monitoring devices market is gaining momentum, driven by the rising prevalence of cardiovascular diseases (CVDs) such as heart failure and coronary artery disease, along with their associated risk factors. According to DelveInsight’s analysis (2024), approximately 621 million people globally were living with heart and circulatory diseases, underscoring a vast and expanding patient pool in need of advanced monitoring solutions. By 2030, over 12.5 million people are projected to be affected by atrial fibrillation, a condition that often requires interventional support to prevent heart failure and related complications. These conditions remain among the leading causes of mortality worldwide, reinforcing the critical role of early detection and continuous monitoring in improving patient outcomes.
Cardiac monitoring devices, including ECGs, Holter monitors, implantable loop recorders, and wearable monitors, play a vital role in tracking cardiac function, identifying abnormalities, and supporting timely interventions. Coronary (ischemic) heart disease, the most common cardiovascular disorder, currently affects about 200 million people worldwide, including 110 million men and 80 million women (British Heart Foundation, 2024). The growing global burden of such conditions is directly fuelling demand for advanced cardiac monitoring technologies.
In addition, the rapid adoption of remote patient monitoring (RPM) is emerging as a major growth driver. As the need for continuous care beyond hospital settings increases, RPM solutions enable real-time monitoring of patients’ heart health at home. Devices such as wearable ECG monitors, wireless Holter systems, and connected implantable recorders transmit live data to healthcare providers, ensuring early detection and timely intervention. For example, in June 2024, Endotronix received FDA Premarket Approval (PMA) for its Cordella PA Sensor System to manage NYHA Class III heart failure patients. The system remotely monitors pulmonary artery pressure alongside non-invasive vitals, enabling clinicians to optimize therapy and reduce hospitalizations. A U.S. launch is expected later this year, with CE mark review underway for European rollout. Taken together, the increasing prevalence of cardiovascular diseases, rising demand for remote monitoring, and ongoing regulatory approvals are expected to significantly drive the growth of the global cardiac monitoring devices market during the forecast period.
The future growth of the cardiac monitoring devices market faces significant challenges, particularly related to the very technology that drives it. The reliance on remote and cloud-based systems introduces critical data privacy and security concerns. As these devices collect highly sensitive health information, the risk of data breaches, unauthorized access, and cyberattacks becomes a major deterrent for both patients and healthcare providers. The fear of a security breach can lead to a lack of trust and adoption, despite the clinical benefits.
Furthermore, the devices themselves have inherent limitations related to data accuracy, reliability, and monitoring duration. Issues such as sensor error, poor connectivity, and inconsistent data transmission can compromise the integrity of the information received by clinicians. The episodic nature of some monitoring devices, as opposed to continuous, real-time tracking, can also lead to critical cardiac events ""slipping through the cracks."" These technical shortcomings, coupled with the need for better patient education and a seamless workflow for healthcare professionals, represent key constraints that may limit the market's full growth potential.
Cardiac Monitoring Devices Market Segment Analysis
Cardiac Monitoring Devices Market by Product Type (ECG Devices [Resting ECG, Stress ECG, and Holter Monitors], Implantable Loop Recorders, Event Recorders, Echocardiogram, Mobile Cardiac Telemetry, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
By Product Type: ECG Devices Category Dominates the Market
In the ECG devices segment of the cardiac monitoring devices market, Holter monitors are projected to hold the largest share at around 57% in 2024, owing to their long-established role as a reliable diagnostic tool for continuous heart rhythm monitoring. Unlike standard ECGs that capture only a brief snapshot of cardiac activity, Holter monitors record data continuously for 24 to 48 hours, making them highly effective in detecting intermittent arrhythmias, silent ischemia, atrial fibrillation, and other irregularities that may not appear during routine clinical evaluations.
Clinicians favor Holter monitors because they are non-invasive, cost-effective, and widely available, positioning them as a first-line option for extended ECG monitoring. Technological advancements—such as wireless and patch-based Holter devices—have further enhanced patient comfort, compliance, and diagnostic accuracy by enabling real-time data transmission to healthcare providers and supporting faster clinical decision-making. For instance, in March 2025 at HIMSS, Peerbridge Health introduced the Cor MDx, a next-generation 3-lead, 2-channel wearable capable of detecting up to 31 arrhythmias while offering features such as 14-day Holter monitoring, mobile cardiac telemetry (MCT), and hemodynamic assessments.
Looking ahead, the integration of artificial intelligence (AI) and advanced analytics into Holter monitoring platforms is expected to transform diagnosis and disease management by improving arrhythmia detection accuracy, reducing clinician workload, and enabling predictive insights. Furthermore, greater interoperability with remote patient monitoring (RPM) platforms will expand their role in long-term disease management, especially for high-risk patients with chronic cardiovascular conditions. These advancements, coupled with sustained adoption in both hospital and ambulatory care settings, will reinforce Holter monitors’ dominance in the ECG devices segment and drive their continued market growth.
By End-User: Hospitals Dominate the Market
Hospitals are boosting the cardiac monitoring devices market by serving as the primary centers for diagnosing, managing, and treating cardiovascular diseases, which remain a leading cause of mortality worldwide. With rising patient admissions for arrhythmias, heart failure, and other cardiac conditions, hospitals increasingly adopt advanced monitoring solutions such as Holter monitors, ECG machines, telemetry systems, and implantable loop recorders to ensure accurate and continuous heart monitoring. Their strong infrastructure, skilled professionals, and integration of remote patient monitoring technologies further drive demand, positioning hospitals as key contributors to the growth of the cardiac monitoring devices market.
Cardiac Monitoring Devices Market Regional Analysis
North America Cardiac Monitoring Devices Market Trends
North America is projected to account for the largest share of the global cardiac monitoring devices market, around 43% in 2024, driven by the high prevalence of cardiovascular diseases, a large aging population, and the early adoption of advanced technologies such as AI-powered wearables and remote monitoring systems. The region’s strong healthcare infrastructure, supportive reimbursement landscape, and continuous FDA approvals for innovative devices further reinforce its leadership position. In addition, the presence of leading market players and growing emphasis on preventive healthcare continue to strengthen market growth.
According to DelveInsight’s analysis (2024), approximately 4.0% of U.S. adults had been diagnosed with coronary heart disease, while an estimated 12.2 million people were living with atrial fibrillation in 2023. Both conditions are major contributors to heart failure and other complications, underscoring the critical need for cardiac monitoring solutions that enable early detection, improved disease management, and better survival outcomes.
Awareness initiatives such as American Heart Month, led by organizations like the American Heart Association (AHA) and the CDC, are further promoting prevention, regular screenings, and continuous monitoring, thereby boosting adoption of cardiac monitoring devices. Ongoing product innovation also fuels growth. For instance, in November 2024, Fourth Frontier received 510(k) clearance for its Frontier X Plus, a single-lead continuous ECG monitor worn around the chest. The device wirelessly transmits ECG data to remote dashboards and leverages advanced algorithms to classify cardiac rhythms such as bradycardia, tachycardia, normal sinus rhythm, and atrial fibrillation.
Taken together, the high disease burden, strong technological uptake, patient awareness, and steady stream of regulatory approvals are expected to drive sustained growth of the cardiac monitoring devices market in North America.
Europe Cardiac Monitoring Devices Market Trends
Europe is driving the growth of the cardiac monitoring devices market through a combination of rising cardiovascular disease prevalence, strong healthcare infrastructure, and supportive regulatory and reimbursement frameworks. As per DelveInsight’s 2023 analysis for the EU4 and UK indicated a higher prevalence of diagnosed atherosclerotic cardiovascular disease (ASCVD) cases was observed in males, nearly 12,601 thousand cases, compared to 8,645 thousand cases in females. Males typically experience ASCVD earlier and face an increased risk of coronary heart disease (CHD) relative to females. This high burden of heart and circulatory diseases has created significant demand for advanced diagnostic and monitoring solutions such as Holter monitors, implantable loop recorders, telemetry systems, and wearable ECG devices.
Additionally, European healthcare providers are increasingly adopting remote patient monitoring and digital health technologies, supported by initiatives to strengthen telemedicine and reduce hospital readmissions. For instance, in January 2024, iRhythm received CE Mark certification under the new EU Medical Device Regulation (MDR) for its next-generation Zio monitor ECG system and its accompanying ZEUS AI-based ECG analysis platform, a significant milestone reinforcing its leadership in ambulatory cardiac monitoring.
With growing investments in AI-powered monitoring, wearable technologies, and cross-border healthcare innovation, Europe continues to play a pivotal role in shaping the expansion of the cardiac monitoring devices market.
Asia-Pacific Cardiac Monitoring Devices Market Trends
The Asia-Pacific region is emerging as a major growth driver of the cardiac monitoring devices market due to a rising prevalence of cardiovascular diseases, a rapidly aging population, and increasing adoption of digital health technologies. Countries like China, India, and Japan are experiencing a surge in heart disease cases driven by lifestyle changes, urbanization, and growing risk factors such as diabetes, obesity, and hypertension. Governments and healthcare providers across the region are investing heavily in modern healthcare infrastructure and promoting remote patient monitoring to improve access to cardiac care in rural and underserved areas. Additionally, the increasing penetration of wearable and portable cardiac monitoring devices, coupled with the rising focus of global players on expanding into emerging Asian markets, is further accelerating market growth. For instance, in May 2025, iRhythm launched its Zio® long-term continuous ECG monitoring (LTCM) system in Japan, offering up to 14 days of continuous monitoring with deep-learning AI algorithms approved by Japan’s PMDA. This provides a significant step-up from traditional Holter monitors.
Thus, the factors mentioned above are expected to boost the market of cardiac monitoring devices across the Asia-Pacific region.
Who are the major players in the cardiac monitoring devices market?
The following are the leading companies in the cardiac monitoring devices market. These companies collectively hold the largest market share and dictate industry trends.
Boston Scientific Corporation
Neurosoft
ACS Diagnostics
Medtronic
BIOTRONIK
Abbott
Microport Scientific Corporation
Koninklijke Philips NV
GENERAL ELECTRIC COMPANY
ZOLL Medical Corporation
AliveCor Inc.
Bexen Cardio
iRhythm Technologies Inc.
Me-Trax GmbH
Osypka Medical GmbH
GE Healthcare
BIOTRONIK SE & Co. KG
Schiller AG
Nihon Kohden Corporation
BPL Medical Technologies Pvt. Ltd.
Others
How is the competitive landscape shaping the cardiac monitoring devices market?
The competitive landscape of the cardiac monitoring devices market is shaping up with a mix of established global players and emerging innovators, creating a highly concentrated market. Leading companies such as Medtronic, GE Healthcare, Philips Healthcare, Abbott, and Boston Scientific dominate the space with strong product portfolios in ECG devices, Holter monitors, telemetry systems, and implantable loop recorders. These firms leverage their global presence, regulatory expertise, and continuous R&D investments to maintain market leadership. At the same time, smaller and mid-sized companies, as well as startups, are intensifying competition by introducing AI-powered, wearable, and remote monitoring solutions tailored to digital health and telemedicine. Market concentration remains high in traditional ECG and Holter devices, but newer segments like wireless and wearable monitoring are more fragmented, attracting new entrants. Strategic collaborations, acquisitions, and regulatory approvals are key tactics shaping competition, while the push for remote patient monitoring and personalized healthcare is driving innovation and market expansion.
Recent Developmental Activities in the Cardiac Monitoring Devices Market
In July 2025, the FDA cleared the CardioTag device, which is the first wearable to simultaneously capture electrocardiogram (ECG), photoplethysmogram (PPG), and seismocardiogram (SCG) signals. This multimodal approach offers enhanced insights into cardiac mechanics and hemodynamics for noninvasive monitoring across care settings.
In March 2025, Sibel Health received its seventh FDA 510(k) clearance for the ANNE One wireless monitoring platform, which captures all vital signs for patients aged 12 and older, including ECG, heart rate, respiration, and more.
In March 2025, at HIMSS, Peerbridge Health unveiled the Cor MDx, a next-generation 3-lead, 2-channel wearable capable of detecting up to 31 arrhythmias and offering features like 14-day Holter monitoring, mobile cardiac telemetry (MCT), and hemodynamic assessments.
In May 2025, iRhythm launched its Zio® long-term continuous ECG monitoring (LTCM) system in Japan, offering up to 14 days of continuous monitoring with deep-learning AI algorithms approved by Japan’s PMDA. This provides a significant step-up from traditional Holter monitors.
In December 2024, HeartBeam, Inc. announced that the US FDA granted 510(k) clearance for its HeartBeam system for comprehensive arrhythmia assessment. The device, a first-of-its-kind high-fidelity ECG system with a credit card-sized, cable-free design, captured heart signals from three directions to provide actionable cardiac insights.
In September 2024, B-Secur received FDA approval for its HeartKey Rhythm suite—AI-driven ECG signal enhancement algorithms designed to improve the quality of third-party ambulatory and consumer ECG devices, facilitating better remote cardiac monitoring accuracy.
Cardiac Monitoring Devices Market Segmentation
Cardiac Monitoring Devices by Product Type Exposure
Stress ECG
Holter Monitors
Canada Cardiac Monitoring Devices Market
Mexico Cardiac Monitoring Devices Market
Germany Cardiac Monitoring Devices Market
France Cardiac Monitoring Devices Market
Italy Cardiac Monitoring Devices Market
Spain Cardiac Monitoring Devices Market
Rest of Europe Cardiac Monitoring Devices Market
Japan Cardiac Monitoring Devices Market
India Cardiac Monitoring Devices Market
Australia Cardiac Monitoring Devices Market
South Korea Cardiac Monitoring Devices Market
Rest of Asia-Pacific Cardiac Monitoring Devices Market
Middle East Cardiac Monitoring Devices Market
Africa Cardiac Monitoring Devices Market
Impact Analysis
AI-Powered Innovations and Applications:
AI-powered innovations and applications are transforming the cardiac monitoring devices market by enabling smarter, faster, and more precise detection and management of cardiovascular conditions. Advanced algorithms integrated into ECG devices, Holter monitors, and wearable cardiac sensors can automatically detect arrhythmias, atrial fibrillation, and other heart abnormalities with high accuracy, reducing reliance on manual interpretation. AI-driven predictive analytics help in identifying patients at risk of cardiac events before they occur, supporting preventive care and timely interventions. Cloud-based platforms powered by AI also facilitate remote patient monitoring, real-time data transmission, and automated alerts to physicians, improving continuity of care. Additionally, AI enhances workflow efficiency in hospitals by analyzing large volumes of cardiac data, reducing diagnostic errors, and optimizing treatment pathways. These innovations not only improve patient outcomes but also align with the growing shift toward personalized medicine and telehealth integration in cardiac care.
U.S. Tariff Impact Analysis on Cardiac Monitoring Devices Market:
The U.S. tariff impact on the cardiac monitoring devices market is relatively limited compared to other medical device categories, but it can still influence import costs, supply chain efficiency, and pricing strategies. Since many components and finished devices are manufactured overseas, tariffs on electronic parts, sensors, and medical equipment can raise production and procurement costs for U.S. healthcare providers and manufacturers. This may lead to higher device prices, affecting hospital budgets and patient affordability. However, strong domestic manufacturing capabilities of leading U.S. players like Medtronic, Abbott, and GE Healthcare help offset dependency on imports, reducing the overall tariff burden. In the long run, tariffs may encourage local sourcing, strategic partnerships, and innovation in domestic production, slightly reshaping the competitive dynamics of the U.S. cardiac monitoring devices market.
How This Analysis Helps Clients
Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.
Key takeaways from the cardiac monitoring devices market report study
1. What is the growth rate of the cardiac monitoring devices market?
The cardiac monitoring devices market is estimated to grow at a CAGR of 5.11% during the forecast period from 2025 to 2032.
2. What is the market for cardiac monitoring devices?
The cardiac monitoring Devices market was valued at USD 21,360.61 million in 2024, and is expected to reach USD 31,602.55 million by 2032.
3. Which region has the highest share in the cardiac monitoring devices market?
North America is expected to dominate the overall cardiac monitoring devices market due to the high prevalence of cardiovascular diseases, a large aging population, and the early adoption of advanced technologies such as AI-powered wearables and remote monitoring systems. Strong healthcare infrastructure, supportive reimbursement policies, and continuous FDA approvals for innovative devices further drive growth. Additionally, the presence of leading market players and increasing focus on preventive healthcare reinforce the region’s dominant position.
4. What are the drivers for the cardiac monitoring devices market?
The overall market for cardiac monitoring devices is being strongly boosted by the rising prevalence of cardiovascular diseases and related risk factors, which heightens the need for early detection and continuous monitoring. This demand is further amplified by the growing adoption of remote patient monitoring, allowing real-time heart health management beyond clinical settings. At the same time, technological advancements in device design, including AI integration, miniaturization, and wearables, are making solutions more accurate and patient-friendly. Additionally, increased product development activities by key players are expanding device options and accessibility, collectively driving robust market growth.
5. Who are the key players operating in the cardiac monitoring devices market?
Some of the key market players operating in the cardiac monitoring devices market include Boston Scientific Corporation, Neurosoft, ACS Diagnostics, Medtronic, BIOTRONIK, Abbott, Microport Scientific Corporation, Koninklijke Philips NV, GENERAL ELECTRIC COMPANY, ZOLL Medical Corporation, AliveCor Inc., Bexen Cardio, iRhythm Technologies Inc., Me-Trax GmbH, Osypka Medical GmbH, GE Healthcare, BIOTRONIK SE & Co. KG, Schiller AG, Nihon Kohden Corporation, BPL Medical Technologies Pvt. Ltd., and others.
The global cardiac monitoring devices market is expected to increase from USD 21,360.61 million in 2024 to USD 31,602.55 million by 2032, reflecting strong and sustained growth.
The global cardiac monitoring devices market is growing at a CAGR of 5.11% during the forecast period from 2025 to 2032.
The market of cardiac monitoring devices is being primarily driven by the growing instances of cardiovascular diseases and their associated risk factors, increasing demand for remote patient monitoring, technological advancements in the product designs, and an increase in product development activities among the key market players.
The leading companies operating in the cardiac monitoring devices market include Boston Scientific Corporation, Neurosoft, ACS Diagnostics, Medtronic, BIOTRONIK, Abbott, Microport Scientific Corporation, Koninklijke Philips NV, GENERAL ELECTRIC COMPANY, ZOLL Medical Corporation, AliveCor Inc., Bexen Cardio, iRhythm Technologies Inc., Me-Trax GmbH, Osypka Medical GmbH, GE Healthcare, BIOTRONIK SE & Co. KG, Schiller AG, Nihon Kohden Corporation, BPL Medical Technologies Pvt. Ltd., and others.
North America is expected to dominate the overall cardiac monitoring devices market due to the high prevalence of cardiovascular diseases, a large aging population, and the early adoption of advanced technologies such as AI-powered wearables and remote monitoring systems. Strong healthcare infrastructure, supportive reimbursement policies, and continuous FDA approvals for innovative devices further drive growth. Additionally, the presence of leading market players and increasing focus on preventive healthcare reinforce the region’s dominant position.
In the product type segment of the cardiac monitoring devices market, the ECG devices category is estimated to account for the largest market share in 2024.
Factors Contributing to the Growth of the Cardiac Monitoring Devices Market
Growing instances of cardiovascular diseases and their associated risk factors leading to a surge in cardiac monitoring devices: The growing instances of cardiovascular diseases, along with associated risk factors such as obesity, diabetes, hypertension, and sedentary lifestyles, are driving a surge in demand for cardiac monitoring devices. With heart conditions becoming a leading cause of morbidity and mortality globally, there is an increasing need for early detection, continuous monitoring, and preventive care, which is fueling the widespread adoption of advanced cardiac monitoring technologies.
Increasing demand for remote patient monitoring is escalating the market of cardiac monitoring devices: The increasing demand for remote patient monitoring is significantly escalating the market for cardiac monitoring devices, as it enables continuous, real-time tracking of heart health outside hospital settings. This trend, accelerated by telehealth adoption, supports better management of chronic conditions, reduces hospital readmissions, and improves patient convenience—driving wider use of wearable ECGs, patches, and implantable monitors worldwide.
Technological advancement in product design: Technological advancements in product design are boosting the cardiac monitoring devices market by introducing smaller, smarter, and more patient-friendly solutions such as wearable ECG patches, AI-powered systems, and wireless implantables. These innovations enhance accuracy, comfort, and connectivity, enabling real-time data sharing and personalized care, which in turn drives greater adoption among both patients and healthcare providers.
Cardiac Monitoring Devices Market Report Segmentation
This cardiac monitoring devices market report offers a comprehensive overview of the global Cardiac Monitoring Devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (ECG Devices [Resting ECG, Stress ECG, and Holter Monitors], Implantable Loop Recorders, Event Recorders, Echocardiogram, Mobile Cardiac Telemetry, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing cardiac monitoring devices market.
A cardiac monitoring device is a medical device that helps in the monitoring of heart rhythms. There are numerous types of cardiac monitoring devices, ranging from conventional cardiac monitors to portable and even implantable cardiac monitors. These devices help in the diagnosis of heart rhythm-related disorders as well as alert patients and healthcare providers during adverse events.
The overall market for cardiac monitoring devices is being strongly boosted by the rising prevalence of cardiovascular diseases and related risk factors, which heightens the need for early detection and continuous monitoring. This demand is further amplified by the growing adoption of remote patient monitoring, allowing real-time heart health management beyond clinical settings. At the same time, technological advancements in device design, including AI integration, miniaturization, and wearables, are making solutions more accurate and patient-friendly. Additionally, increased product development activities by key players are expanding device options and accessibility, collectively driving robust market growth.
Get More Insights into the Report @Cardiac Monitoring Devices Market
What are the latest Cardiac Monitoring Devices Market Dynamics and Trends?
The cardiac monitoring devices market is gaining momentum, driven by the rising prevalence of cardiovascular diseases (CVDs) such as heart failure and coronary artery disease, along with their associated risk factors. According to DelveInsight’s analysis (2024), approximately 621 million people globally were living with heart and circulatory diseases, underscoring a vast and expanding patient pool in need of advanced monitoring solutions. By 2030, over 12.5 million people are projected to be affected by atrial fibrillation, a condition that often requires interventional support to prevent heart failure and related complications. These conditions remain among the leading causes of mortality worldwide, reinforcing the critical role of early detection and continuous monitoring in improving patient outcomes.
Cardiac monitoring devices, including ECGs, Holter monitors, implantable loop recorders, and wearable monitors, play a vital role in tracking cardiac function, identifying abnormalities, and supporting timely interventions. Coronary (ischemic) heart disease, the most common cardiovascular disorder, currently affects about 200 million people worldwide, including 110 million men and 80 million women (British Heart Foundation, 2024). The growing global burden of such conditions is directly fuelling demand for advanced cardiac monitoring technologies.
In addition, the rapid adoption of remote patient monitoring (RPM) is emerging as a major growth driver. As the need for continuous care beyond hospital settings increases, RPM solutions enable real-time monitoring of patients’ heart health at home. Devices such as wearable ECG monitors, wireless Holter systems, and connected implantable recorders transmit live data to healthcare providers, ensuring early detection and timely intervention. For example, in June 2024, Endotronix received FDA Premarket Approval (PMA) for its Cordella PA Sensor System to manage NYHA Class III heart failure patients. The system remotely monitors pulmonary artery pressure alongside non-invasive vitals, enabling clinicians to optimize therapy and reduce hospitalizations. A U.S. launch is expected later this year, with CE mark review underway for European rollout. Taken together, the increasing prevalence of cardiovascular diseases, rising demand for remote monitoring, and ongoing regulatory approvals are expected to significantly drive the growth of the global cardiac monitoring devices market during the forecast period.
The future growth of the cardiac monitoring devices market faces significant challenges, particularly related to the very technology that drives it. The reliance on remote and cloud-based systems introduces critical data privacy and security concerns. As these devices collect highly sensitive health information, the risk of data breaches, unauthorized access, and cyberattacks becomes a major deterrent for both patients and healthcare providers. The fear of a security breach can lead to a lack of trust and adoption, despite the clinical benefits.
Furthermore, the devices themselves have inherent limitations related to data accuracy, reliability, and monitoring duration. Issues such as sensor error, poor connectivity, and inconsistent data transmission can compromise the integrity of the information received by clinicians. The episodic nature of some monitoring devices, as opposed to continuous, real-time tracking, can also lead to critical cardiac events ""slipping through the cracks."" These technical shortcomings, coupled with the need for better patient education and a seamless workflow for healthcare professionals, represent key constraints that may limit the market's full growth potential.
Cardiac Monitoring Devices Market Segment Analysis
Cardiac Monitoring Devices Market by Product Type (ECG Devices [Resting ECG, Stress ECG, and Holter Monitors], Implantable Loop Recorders, Event Recorders, Echocardiogram, Mobile Cardiac Telemetry, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
By Product Type: ECG Devices Category Dominates the Market
In the ECG devices segment of the cardiac monitoring devices market, Holter monitors are projected to hold the largest share at around 57% in 2024, owing to their long-established role as a reliable diagnostic tool for continuous heart rhythm monitoring. Unlike standard ECGs that capture only a brief snapshot of cardiac activity, Holter monitors record data continuously for 24 to 48 hours, making them highly effective in detecting intermittent arrhythmias, silent ischemia, atrial fibrillation, and other irregularities that may not appear during routine clinical evaluations.
Clinicians favor Holter monitors because they are non-invasive, cost-effective, and widely available, positioning them as a first-line option for extended ECG monitoring. Technological advancements—such as wireless and patch-based Holter devices—have further enhanced patient comfort, compliance, and diagnostic accuracy by enabling real-time data transmission to healthcare providers and supporting faster clinical decision-making. For instance, in March 2025 at HIMSS, Peerbridge Health introduced the Cor MDx, a next-generation 3-lead, 2-channel wearable capable of detecting up to 31 arrhythmias while offering features such as 14-day Holter monitoring, mobile cardiac telemetry (MCT), and hemodynamic assessments.
Looking ahead, the integration of artificial intelligence (AI) and advanced analytics into Holter monitoring platforms is expected to transform diagnosis and disease management by improving arrhythmia detection accuracy, reducing clinician workload, and enabling predictive insights. Furthermore, greater interoperability with remote patient monitoring (RPM) platforms will expand their role in long-term disease management, especially for high-risk patients with chronic cardiovascular conditions. These advancements, coupled with sustained adoption in both hospital and ambulatory care settings, will reinforce Holter monitors’ dominance in the ECG devices segment and drive their continued market growth.
By End-User: Hospitals Dominate the Market
Hospitals are boosting the cardiac monitoring devices market by serving as the primary centers for diagnosing, managing, and treating cardiovascular diseases, which remain a leading cause of mortality worldwide. With rising patient admissions for arrhythmias, heart failure, and other cardiac conditions, hospitals increasingly adopt advanced monitoring solutions such as Holter monitors, ECG machines, telemetry systems, and implantable loop recorders to ensure accurate and continuous heart monitoring. Their strong infrastructure, skilled professionals, and integration of remote patient monitoring technologies further drive demand, positioning hospitals as key contributors to the growth of the cardiac monitoring devices market.
Cardiac Monitoring Devices Market Regional Analysis
North America Cardiac Monitoring Devices Market Trends
North America is projected to account for the largest share of the global cardiac monitoring devices market, around 43% in 2024, driven by the high prevalence of cardiovascular diseases, a large aging population, and the early adoption of advanced technologies such as AI-powered wearables and remote monitoring systems. The region’s strong healthcare infrastructure, supportive reimbursement landscape, and continuous FDA approvals for innovative devices further reinforce its leadership position. In addition, the presence of leading market players and growing emphasis on preventive healthcare continue to strengthen market growth.
According to DelveInsight’s analysis (2024), approximately 4.0% of U.S. adults had been diagnosed with coronary heart disease, while an estimated 12.2 million people were living with atrial fibrillation in 2023. Both conditions are major contributors to heart failure and other complications, underscoring the critical need for cardiac monitoring solutions that enable early detection, improved disease management, and better survival outcomes.
Awareness initiatives such as American Heart Month, led by organizations like the American Heart Association (AHA) and the CDC, are further promoting prevention, regular screenings, and continuous monitoring, thereby boosting adoption of cardiac monitoring devices. Ongoing product innovation also fuels growth. For instance, in November 2024, Fourth Frontier received 510(k) clearance for its Frontier X Plus, a single-lead continuous ECG monitor worn around the chest. The device wirelessly transmits ECG data to remote dashboards and leverages advanced algorithms to classify cardiac rhythms such as bradycardia, tachycardia, normal sinus rhythm, and atrial fibrillation.
Taken together, the high disease burden, strong technological uptake, patient awareness, and steady stream of regulatory approvals are expected to drive sustained growth of the cardiac monitoring devices market in North America.
Europe Cardiac Monitoring Devices Market Trends
Europe is driving the growth of the cardiac monitoring devices market through a combination of rising cardiovascular disease prevalence, strong healthcare infrastructure, and supportive regulatory and reimbursement frameworks. As per DelveInsight’s 2023 analysis for the EU4 and UK indicated a higher prevalence of diagnosed atherosclerotic cardiovascular disease (ASCVD) cases was observed in males, nearly 12,601 thousand cases, compared to 8,645 thousand cases in females. Males typically experience ASCVD earlier and face an increased risk of coronary heart disease (CHD) relative to females. This high burden of heart and circulatory diseases has created significant demand for advanced diagnostic and monitoring solutions such as Holter monitors, implantable loop recorders, telemetry systems, and wearable ECG devices.
Additionally, European healthcare providers are increasingly adopting remote patient monitoring and digital health technologies, supported by initiatives to strengthen telemedicine and reduce hospital readmissions. For instance, in January 2024, iRhythm received CE Mark certification under the new EU Medical Device Regulation (MDR) for its next-generation Zio monitor ECG system and its accompanying ZEUS AI-based ECG analysis platform, a significant milestone reinforcing its leadership in ambulatory cardiac monitoring.
With growing investments in AI-powered monitoring, wearable technologies, and cross-border healthcare innovation, Europe continues to play a pivotal role in shaping the expansion of the cardiac monitoring devices market.
Asia-Pacific Cardiac Monitoring Devices Market Trends
The Asia-Pacific region is emerging as a major growth driver of the cardiac monitoring devices market due to a rising prevalence of cardiovascular diseases, a rapidly aging population, and increasing adoption of digital health technologies. Countries like China, India, and Japan are experiencing a surge in heart disease cases driven by lifestyle changes, urbanization, and growing risk factors such as diabetes, obesity, and hypertension. Governments and healthcare providers across the region are investing heavily in modern healthcare infrastructure and promoting remote patient monitoring to improve access to cardiac care in rural and underserved areas. Additionally, the increasing penetration of wearable and portable cardiac monitoring devices, coupled with the rising focus of global players on expanding into emerging Asian markets, is further accelerating market growth. For instance, in May 2025, iRhythm launched its Zio® long-term continuous ECG monitoring (LTCM) system in Japan, offering up to 14 days of continuous monitoring with deep-learning AI algorithms approved by Japan’s PMDA. This provides a significant step-up from traditional Holter monitors.
Thus, the factors mentioned above are expected to boost the market of cardiac monitoring devices across the Asia-Pacific region.
Who are the major players in the cardiac monitoring devices market?
The following are the leading companies in the cardiac monitoring devices market. These companies collectively hold the largest market share and dictate industry trends.
Boston Scientific Corporation
Neurosoft
ACS Diagnostics
Medtronic
BIOTRONIK
Abbott
Microport Scientific Corporation
Koninklijke Philips NV
GENERAL ELECTRIC COMPANY
ZOLL Medical Corporation
AliveCor Inc.
Bexen Cardio
iRhythm Technologies Inc.
Me-Trax GmbH
Osypka Medical GmbH
GE Healthcare
BIOTRONIK SE & Co. KG
Schiller AG
Nihon Kohden Corporation
BPL Medical Technologies Pvt. Ltd.
Others
How is the competitive landscape shaping the cardiac monitoring devices market?
The competitive landscape of the cardiac monitoring devices market is shaping up with a mix of established global players and emerging innovators, creating a highly concentrated market. Leading companies such as Medtronic, GE Healthcare, Philips Healthcare, Abbott, and Boston Scientific dominate the space with strong product portfolios in ECG devices, Holter monitors, telemetry systems, and implantable loop recorders. These firms leverage their global presence, regulatory expertise, and continuous R&D investments to maintain market leadership. At the same time, smaller and mid-sized companies, as well as startups, are intensifying competition by introducing AI-powered, wearable, and remote monitoring solutions tailored to digital health and telemedicine. Market concentration remains high in traditional ECG and Holter devices, but newer segments like wireless and wearable monitoring are more fragmented, attracting new entrants. Strategic collaborations, acquisitions, and regulatory approvals are key tactics shaping competition, while the push for remote patient monitoring and personalized healthcare is driving innovation and market expansion.
Recent Developmental Activities in the Cardiac Monitoring Devices Market
In July 2025, the FDA cleared the CardioTag device, which is the first wearable to simultaneously capture electrocardiogram (ECG), photoplethysmogram (PPG), and seismocardiogram (SCG) signals. This multimodal approach offers enhanced insights into cardiac mechanics and hemodynamics for noninvasive monitoring across care settings.
In March 2025, Sibel Health received its seventh FDA 510(k) clearance for the ANNE One wireless monitoring platform, which captures all vital signs for patients aged 12 and older, including ECG, heart rate, respiration, and more.
In March 2025, at HIMSS, Peerbridge Health unveiled the Cor MDx, a next-generation 3-lead, 2-channel wearable capable of detecting up to 31 arrhythmias and offering features like 14-day Holter monitoring, mobile cardiac telemetry (MCT), and hemodynamic assessments.
In May 2025, iRhythm launched its Zio® long-term continuous ECG monitoring (LTCM) system in Japan, offering up to 14 days of continuous monitoring with deep-learning AI algorithms approved by Japan’s PMDA. This provides a significant step-up from traditional Holter monitors.
In December 2024, HeartBeam, Inc. announced that the US FDA granted 510(k) clearance for its HeartBeam system for comprehensive arrhythmia assessment. The device, a first-of-its-kind high-fidelity ECG system with a credit card-sized, cable-free design, captured heart signals from three directions to provide actionable cardiac insights.
In September 2024, B-Secur received FDA approval for its HeartKey Rhythm suite—AI-driven ECG signal enhancement algorithms designed to improve the quality of third-party ambulatory and consumer ECG devices, facilitating better remote cardiac monitoring accuracy.
Cardiac Monitoring Devices Market Segmentation
Cardiac Monitoring Devices by Product Type Exposure
- ECG Devices
Stress ECG
Holter Monitors
- Implantable Loop Recorders
- Event Recorders
- Echocardiogram
- Mobile Cardiac Telemetry
- Others
- Hospitals
- Ambulatory Surgical Centers
- Homecare Settings
- Others
- North America Cardiac Monitoring Devices Market
Canada Cardiac Monitoring Devices Market
Mexico Cardiac Monitoring Devices Market
- Europe Cardiac Monitoring Devices Market
Germany Cardiac Monitoring Devices Market
France Cardiac Monitoring Devices Market
Italy Cardiac Monitoring Devices Market
Spain Cardiac Monitoring Devices Market
Rest of Europe Cardiac Monitoring Devices Market
- Asia-Pacific Cardiac Monitoring Devices Market
Japan Cardiac Monitoring Devices Market
India Cardiac Monitoring Devices Market
Australia Cardiac Monitoring Devices Market
South Korea Cardiac Monitoring Devices Market
Rest of Asia-Pacific Cardiac Monitoring Devices Market
- Rest of the World Cardiac Monitoring Devices Market
Middle East Cardiac Monitoring Devices Market
Africa Cardiac Monitoring Devices Market
Impact Analysis
AI-Powered Innovations and Applications:
AI-powered innovations and applications are transforming the cardiac monitoring devices market by enabling smarter, faster, and more precise detection and management of cardiovascular conditions. Advanced algorithms integrated into ECG devices, Holter monitors, and wearable cardiac sensors can automatically detect arrhythmias, atrial fibrillation, and other heart abnormalities with high accuracy, reducing reliance on manual interpretation. AI-driven predictive analytics help in identifying patients at risk of cardiac events before they occur, supporting preventive care and timely interventions. Cloud-based platforms powered by AI also facilitate remote patient monitoring, real-time data transmission, and automated alerts to physicians, improving continuity of care. Additionally, AI enhances workflow efficiency in hospitals by analyzing large volumes of cardiac data, reducing diagnostic errors, and optimizing treatment pathways. These innovations not only improve patient outcomes but also align with the growing shift toward personalized medicine and telehealth integration in cardiac care.
U.S. Tariff Impact Analysis on Cardiac Monitoring Devices Market:
The U.S. tariff impact on the cardiac monitoring devices market is relatively limited compared to other medical device categories, but it can still influence import costs, supply chain efficiency, and pricing strategies. Since many components and finished devices are manufactured overseas, tariffs on electronic parts, sensors, and medical equipment can raise production and procurement costs for U.S. healthcare providers and manufacturers. This may lead to higher device prices, affecting hospital budgets and patient affordability. However, strong domestic manufacturing capabilities of leading U.S. players like Medtronic, Abbott, and GE Healthcare help offset dependency on imports, reducing the overall tariff burden. In the long run, tariffs may encourage local sourcing, strategic partnerships, and innovation in domestic production, slightly reshaping the competitive dynamics of the U.S. cardiac monitoring devices market.
How This Analysis Helps Clients
Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.
Key takeaways from the cardiac monitoring devices market report study
- Market size analysis for the current cardiac monitoring devices market size (2024), and market forecast for 8 years (2025 to 2032)
- Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
- Key companies dominating the cardiac monitoring devices market.
- Various opportunities available for the other competitors in the cardiac monitoring devices market space.
- What are the top-performing segments in 2024How these segments will perform in 2032?
- Which are the top-performing regions and countries in the current cardiac monitoring devices market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for the cardiac monitoring devices market growth in the future?
1. What is the growth rate of the cardiac monitoring devices market?
The cardiac monitoring devices market is estimated to grow at a CAGR of 5.11% during the forecast period from 2025 to 2032.
2. What is the market for cardiac monitoring devices?
The cardiac monitoring Devices market was valued at USD 21,360.61 million in 2024, and is expected to reach USD 31,602.55 million by 2032.
3. Which region has the highest share in the cardiac monitoring devices market?
North America is expected to dominate the overall cardiac monitoring devices market due to the high prevalence of cardiovascular diseases, a large aging population, and the early adoption of advanced technologies such as AI-powered wearables and remote monitoring systems. Strong healthcare infrastructure, supportive reimbursement policies, and continuous FDA approvals for innovative devices further drive growth. Additionally, the presence of leading market players and increasing focus on preventive healthcare reinforce the region’s dominant position.
4. What are the drivers for the cardiac monitoring devices market?
The overall market for cardiac monitoring devices is being strongly boosted by the rising prevalence of cardiovascular diseases and related risk factors, which heightens the need for early detection and continuous monitoring. This demand is further amplified by the growing adoption of remote patient monitoring, allowing real-time heart health management beyond clinical settings. At the same time, technological advancements in device design, including AI integration, miniaturization, and wearables, are making solutions more accurate and patient-friendly. Additionally, increased product development activities by key players are expanding device options and accessibility, collectively driving robust market growth.
5. Who are the key players operating in the cardiac monitoring devices market?
Some of the key market players operating in the cardiac monitoring devices market include Boston Scientific Corporation, Neurosoft, ACS Diagnostics, Medtronic, BIOTRONIK, Abbott, Microport Scientific Corporation, Koninklijke Philips NV, GENERAL ELECTRIC COMPANY, ZOLL Medical Corporation, AliveCor Inc., Bexen Cardio, iRhythm Technologies Inc., Me-Trax GmbH, Osypka Medical GmbH, GE Healthcare, BIOTRONIK SE & Co. KG, Schiller AG, Nihon Kohden Corporation, BPL Medical Technologies Pvt. Ltd., and others.
Table of Contents
150 Pages
- 1. Cardiac Monitoring Devices Market Report Introduction
- 1.1 Scope of the Study
- 1.2 Market Segmentation
- 1.3 Market Assumption
- 2. Cardiac Monitoring Devices Market Executive Summary
- 2.1 Market at Glance
- 3. Cardiac Monitoring Devices Market Key Factors Analysis
- 3.1 Cardiac Monitoring Devices Market Drivers
- 3.1.1 Growing instances of cardiovascular diseases and their associated risk factors
- 3.1.2 Increasing demand for remote patient monitoring
- 3.1.3 Increase in technological advancement
- 3.1.4 Increase in product development activities among the key market players
- 3.2 Cardiac Monitoring Devices Market Restraints and Challenges
- 3.2.1 Data privacy and security
- 3.2.2 Limitations associated with the devices
- 3.3 Cardiac Monitoring Devices Market Opportunity
- 3.3.1 Integration of AI and machine learning for the interpretation of cardiac data
- 4. Impact Analysis
- 4.1 AI-Powered Innovations and Applications
- 4.2 U.S. Tariff Impact Analysis
- 5. Regulatory Analysis
- 5.1 The United States
- 5.2 Europe
- 5.3 Japan
- 5.4 China
- 6. Cardiac Monitoring Devices Market Porter’s Five Forces Analysis
- 6.1 Bargaining Power of Suppliers
- 6.2 Bargaining Power of Consumers
- 6.3 Threat of New Entrants
- 6.4 Threat of Substitutes
- 6.5 Competitive Rivalry
- 7. Cardiac Monitoring Devices Market Assessment
- 7.1 By Product Type
- 7.1.1 ECG Devices
- 7.1.1.1 Resting ECG
- 7.1.1.2 Stress ECG
- 7.1.1.3 Holter Monitors
- 7.1.2 Implantable Loop Recorders
- 7.1.3 Event Recorders
- 7.1.4 Echocardiogram
- 7.1.5 Mobile Cardiac Telemetry
- 7.1.6 Others
- 7.2 By End-Users
- 7.2.1 Hospitals
- 7.2.2 Ambulatory Surgical Centers
- 7.2.3 Homecare Settings
- 7.2.4 Others
- 7.3 By Geography
- 7.3.1 North America
- 7.3.1.1 United States Cardiac Monitoring Devices Market Size in USD million (2022-2032)
- 7.3.1.2 Canada Cardiac Monitoring Devices Market Size in USD million (2022-2032)
- 7.3.1.3 Mexico Cardiac Monitoring Devices Market Size in USD million (2022-2032)
- 7.3.2 Europe
- 7.3.2.1 France Cardiac Monitoring Devices Market Size in USD million (2022-2032)
- 7.3.2.2 Germany Cardiac Monitoring Devices Market Size in USD million (2022-2032)
- 7.3.2.3 United Kingdom Cardiac Monitoring Devices Market Size in USD million (2022-2032)
- 7.3.2.4 Italy Cardiac Monitoring Devices Market Size in USD million (2022-2032)
- 7.3.2.5 Spain Cardiac Monitoring Devices Market Size in USD million (2022-2032)
- 7.3.2.6 Rest of Europe Cardiac Monitoring Devices Market Size in USD million (2022-2032)
- 7.3.3 Asia-Pacific
- 7.3.3.1 China Cardiac Monitoring Devices Market Size in USD million (2022-2032)
- 7.3.3.2 Japan Cardiac Monitoring Devices Market Size in USD million (2022-2032)
- 7.3.3.3 India Cardiac Monitoring Devices Market Size in USD million (2022-2032)
- 7.3.3.4 Australia Cardiac Monitoring Devices Market Size in USD million (2022-2032)
- 7.3.3.5 South Korea Cardiac Monitoring Devices Market Size in USD million (2022-2032)
- 7.3.3.6 Rest of Asia-Pacific Cardiac Monitoring Devices Market Size in USD million (2022-2032)
- 7.3.4 Rest of the World (RoW)
- 7.3.4.1 Middle East Cardiac Monitoring Devices Market Size in USD million (2022-2032)
- 7.3.4.2 Africa Cardiac Monitoring Devices Market Size in USD million (2022-2032)
- 7.3.4.3 South America Cardiac Monitoring Devices Market Size In USD Million (2022-2032)
- 8. Competitive Landscape
- 9. Startup Funding & Investment Trends
- 10. Cardiac Monitoring Devices Market Company and Product Profiles
- 10.1 Boston Scientific Corporation
- 10.1.1 Company Overview
- 10.1.2 Company Snapshot
- 10.1.3 Financial Overview
- 10.1.4 Product Listing
- 10.1.5 Entropy
- 10.2 Neurosoft
- 10.2.1 Company Overview
- 10.2.2 Company Snapshot
- 10.2.3 Financial Overview
- 10.2.4 Product Listing
- 10.2.5 Entropy
- 10.3 ACS Diagnostics
- 10.3.1 Company Overview
- 10.3.2 Company Snapshot
- 10.3.3 Financial Overview
- 10.3.4 Product Listing
- 10.3.5 Entropy
- 10.4 Medtronic
- 10.4.1 Company Overview
- 10.4.2 Company Snapshot
- 10.4.3 Financial Overview
- 10.4.4 Product Listing
- 10.4.5 Entropy
- 10.5 BIOTRONIK
- 10.5.1 Company Overview
- 10.5.2 Company Snapshot
- 10.5.3 Financial Overview
- 10.5.4 Product Listing
- 10.5.5 Entropy
- 10.6 Abbott
- 10.6.1 Company Overview
- 10.6.2 Company Snapshot
- 10.6.3 Financial Overview
- 10.6.4 Product Listing
- 10.6.5 Entropy
- 10.7 Microport Scientific Corporation
- 10.7.1 Company Overview
- 10.7.2 Company Snapshot
- 10.7.3 Financial Overview
- 10.7.4 Product Listing
- 10.7.5 Entropy
- 10.8 Koninklijke Philips NV
- 10.8.1 Company Overview
- 10.8.2 Company Snapshot
- 10.8.3 Financial Overview
- 10.8.4 Product Listing
- 10.8.5 Entropy
- 10.9 GENERAL ELECTRIC COMPANY
- 10.9.1 Company Overview
- 10.9.2 Company Snapshot
- 10.9.3 Financial Overview
- 10.9.4 Product Listing
- 10.9.5 Entropy
- 10.10 ZOLL Medical Corporation
- 10.10.1 Company Overview
- 10.10.2 Company Snapshot
- 10.10.3 Financial Overview
- 10.10.4 Product Listing
- 10.10.5 Entropy
- 10.11 AliveCor Inc.
- 10.11.1 Company Overview
- 10.11.2 Company Snapshot
- 10.11.3 Financial Overview
- 10.11.4 Product Listing
- 10.11.5 Entropy
- 10.12 Bexen Cardio
- 10.12.1 Company Overview
- 10.12.2 Company Snapshot
- 10.12.3 Financial Overview
- 10.12.4 Product Listing
- 10.12.5 Entropy
- 10.13 iRhythm Technologies Inc.
- 10.13.1 Company Overview
- 10.13.2 Company Snapshot
- 10.13.3 Financial Overview
- 10.13.4 Product Listing
- 10.13.5 Entropy
- 10.14 Me-Trax GmbH
- 10.14.1 Company Overview
- 10.14.2 Company Snapshot
- 10.14.3 Financial Overview
- 10.14.4 Product Listing
- 10.14.5 Entropy
- 10.15 Osypka Medical GmbH
- 10.15.1 Company Overview
- 10.15.2 Company Snapshot
- 10.15.3 Financial Overview
- 10.15.4 Product Listing
- 10.15.5 Entropy
- 10.16 GE Healthcare
- 10.16.1 Company Overview
- 10.16.2 Company Snapshot
- 10.16.3 Financial Overview
- 10.16.4 Product Listing
- 10.16.5 Entropy
- 10.17 BIOTRONIK SE & Co. KG
- 10.17.1 Company Overview
- 10.17.2 Company Snapshot
- 10.17.3 Financial Overview
- 10.17.4 Product Listing
- 10.17.5 Entropy
- 10.18 Schiller AG
- 10.18.1 Company Overview
- 10.18.2 Company Snapshot
- 10.18.3 Financial Overview
- 10.18.4 Product Listing
- 10.18.5 Entropy
- 10.19 Nihon Kohden Corporation, BPL Medical Technologies Pvt. Ltd.
- 10.19.1 Company Overview
- 10.19.2 Company Snapshot
- 10.19.3 Financial Overview
- 10.19.4 Product Listing
- 10.19.5 Entropy
- 10.20 BPL Medical Technologies Pvt. Ltd.
- 10.20.1 Company Overview
- 10.20.2 Company Snapshot
- 10.20.3 Financial Overview
- 10.20.4 Product Listing
- 10.20.5 Entropy
- 11. KOL Views
- 12. Project Approach
- 13. About DelveInsight
- 14. Disclaimer & Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.